Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1648 of 6351
-
Can Platelet-Rich plasma heal stubborn wounds faster than saline?
Disease control CompletedThis randomized controlled trial will compare platelet rich plasma dressing with normal saline dressing for the treatment of chronic non healing cutaneous ulcers, including diabetic foot ulcers, venous leg ulcers, pressure ulcers, and other suitable chronic ulcers of at least six…
Sponsor: Multan Medical And Dental College • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New shot shows promise against tough lung cancer
Disease control OngoingThis study will evaluate the efficacy, safety, pharmacokinetics and immunogenicity of RC148 injection as a single agent or in combination for the treatment of locally advanced or metastatic non-small cell lung cancer
Phase 1 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could a concentrated dose of your own healing factors ease knee arthritis?
Disease control CompletedThe goal of this clinical trial is to evaluate the effectiveness and safety of an autologous platelet-rich concentrated growth factor (CGF) preparation kit for the treatment of knee osteoarthritis in patients diagnosed with this condition. The main question it aims to answer is: …
Sponsor: Guangdong Hongzhi Health Technology • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Heart stent study tests if extra ultrasound imaging saves lives
Disease control Recruiting nowCoronary artery disease is associated with substantial morbidity and mortality worldwide. Percutaneous coronary intervention (PCI) is a pivotal procedure for the treatment of coronary artery disease. Although coronary angiography (CA) is the standard imaging modality used for cor…
Sponsor: SUK MIN SEO • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New study aims to get more latino teens the HPV vaccine
Prevention Recruiting nowThe purpose of this study is to determine the provider- and practice-level characteristics that influence the impact of implementation strategies guided by practice facilitation in each clinical practice, to test whether the facilitator-driven provider- and practice-level impleme…
Sponsor: The University of Texas Health Science Center, Houston • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC
-
Brain training boosts therapy for BPD?
Symptom relief Recruiting nowThe purpose of this study is to test the ability of mindfulness-based real time functional magnetic resonance imaging (fMRI) neurofeedback (mbNF) to increase the benefits of evidence-based psychotherapy for adults with Borderline Personality Disorder (BPD).
Phase 2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Online program aims to slash dementia risk with personalized lifestyle coaching
Prevention OngoingAlzheimer's Disease (AD) and other Dementias have far-reaching consequences on the lives of sufferers and their loved ones, not to mention the impact on the healthcare system. Several studies have identified protective lifestyle habits that might help reduce the risk of cognitive…
Phase 3 • Sponsor: LuciLab • Aim: Prevention
Last updated Aug 27, 2026 00:00 UTC
-
New combo therapy hopes to shrink Hard-to-Treat cancers
Disease control OngoingThis is a non-randomized, open-label, dose-escalation, and dose-expansion Phase Ib/IIa study to evaluate the safety, tolerability, PK, PD, and preliminary antitumor activity of HCB101 administered in combination with standard or approved anticancer therapies in subjects with adva…
Phase 1/2 • Sponsor: FBD Biologics Limited • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Online CBT may slow memory loss in depressed ICU seniors
Symptom relief Recruiting nowDepression affects one-third of intensive care unit (ICU) survivors and represents a potentially modifiable target to slow cognitive decline and reduce the risk of Alzheimer's disease and related dementias (ADRD). Our multi-PI team proposes a two-arm RCT called ADEPT-ICU (Attenua…
Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Can stress patterns in teens predict a loss of joy?
Knowledge-focused Recruiting nowThis project will examine how multiple biological measures from the brain and the body's stress response system contribute to anhedonia (the loss of pleasure) in adolescence. The goal of this project is to see if it is possible to combine these biological measures to describe dif…
Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
New shot could help diabetics shed pounds on top of existing meds
Disease control OngoingThis Phase II study is a randomized, parallel group, double blinded, placebo-controlled, multicenter to evaluate the efficacy, safety, and tolerability of AZD6234 in adults with overweight or obesity and type 2 diabetes on stable GLP-1 RA therapy.
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
AI tool aims to unmask genetic diseases in kids faster
Knowledge-focused OngoingThis study will evaluate the effectiveness of SIGHT as a clinical support system to prompt provider/patient discussion and shared decision making regarding the need for genetic testing in the form of a chromosomal microarray. Identifying patients at high predicted probability of …
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Stem cell shot aims to seal Crohn's fistulas
Disease control Recruiting nowPerianal fistulas are in the forefront (42 to 72, 4%) of morbid complication of Crohn's disease, affecting nearly one- third of patients and complicating abscesses in 35-48% of cases. The current treatment is based on the combination of drainage (proctologic and surgical), and bi…
Phase 1/2 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New study tackles stigma and shame to help people with HIV and addiction get healthy
Disease control Recruiting nowPeople living with HIV and substance use disorders (SUDs) are less likely to be virally suppressed, which can lead to HIV transmission and negative health outcomes. This hybrid type 1 study will assess the efficacy, mechanisms, as well as facilitators and barriers to implementing…
Sponsor: Boston University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New chemo formula could cut side effects in lymphoma transplants
Disease control Recruiting nowA phase 2 multicenter study of VI-0609 vs BiCNU in the BEAM high-intensity conditioning regimen for AHCT in subjects with lymphomas.
Phase 2 • Sponsor: VIVUS LLC • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Silver shield for hips: new implant aims to stop infections
Disease control Recruiting nowThe aim of the present clinical study, of prospective observational nature with biological study, is to conduct a clinical investigation on the the efficacy of a device coated with bacteriostatic silver coating, with the overall objective of understand whether the device is indee…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Singing together may ease dementia symptoms, small study hints
Symptom relief CompletedThis study intends to investigate whether a singing programme for nursing home residents living with dementia can reduce the mental and physiological effects of dementia. The main questions it aims to answer are: 1. Does participating in the Sing Out Loud (SOL) singing intervent…
Sponsor: National University of Singapore • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a mood stabilizer help fight colorectal cancer?
Disease control Recruiting nowThe investigators hypothesize that the epigenetic agent valproic acid improve the activity of anti-EGFR agents, prevent and revert the emergence of EGFR resistance, in a rechallenge setting. Correlative mechanistic studies on tissue and blood samples, liquid biopsies, could iden…
Phase 2 • Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New pill elismetrep aims to zap migraine pain in Mid-Stage trial
Symptom relief CompletedThis is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep as compared to placebo in the acute treatment of migraine.
Phase 2 • Sponsor: Kallyope Inc. • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
New hope for kids with arthritis: drug trial launches
Disease control Recruiting nowThe purpose of this study is to assess plasma bimekizumab concentrations following subcutaneous (sc) bimekizumab administration.
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC